Patients taking Ozempic for diabetes or weight loss now face a newly recognized threat to their eyesight. Federal regulators ...

A study published in JAMA Ophthalmology has identified a potential link between popular weight-loss medications and severe, ...

A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of ...

Learning to read again Study participant Sheila Irvine, a patient at Moorfields Eye Hospital, training with the PRIMA device. (Courtesy: Moorfields Eye Hospital) A tiny wireless implant inserted under ...

Doris is an 86-year-old woman who has been experiencing blurred vision in the left eye for the past month. B. Assessment and diagnosis only; I refer for treatment. C. Assessment only; I refer for ...

Please provide your email address to receive an email when new articles are posted on . A 42-year-old man with no significant medical history was urgently referred to New England Eye Center in July ...

Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...

New research suggests that weight-loss drugs can help prevent vision loss as patients age, but there’s a major caveat. GLP-1 weight-loss drugs linked to reduced risk of age-related macular ...

Age-related macular degeneration (AMD) is a common eye condition in older adults that can affect central vision. Geographic atrophy is an advanced form of AMD that causes permanent vision changes.

A groundbreaking study published in The New England Journal of Medicine (NEJM) on Monday demonstrates how specialized devices using artificial intelligence can help restore central vision to treat ...